About the Company
Merck & Co., Inc. is an American multinational pharmaceutical company headquartered in Rahway, New Jersey, and is named for Merck Group, founded in Germany in 1668, of which it was once the American arm. The company does business as Merck Sharp & Dohme or MSD outside the United States and Canada. It is one of the largest pharmaceutical companies in the world, generally ranking in the global top five by revenue. Merck & Co. was originally established as the American affiliate of Merck Group in 1891. Merck develops and produces medicines, vaccines, biologic therapies and animal health products. It has multiple blockbuster drugs or products each with 2020 revenues including cancer immunotherapy, anti-diabetic medication and vaccines against HPV and chickenpox. The company is ranked 71st on the 2022 Fortune 500 and 87th on the 2022 Forbes Global 2000, both based on 2021 revenues. In 2023, the company’s seat in Forbes Global 2000 was 73.
Exchange
NYSE
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $MRK News
Merck may have a competition for ever-scarce BCG
There’s long been a global shortage of the BCG vaccine for bladder cancer. But since ImmunityBio won FDA approval for Anktiva ...
Is Merck Stock Fully Valued At $130?
In this photo illustration, the Merck Sharp and Dohme logo is displayed on a ... [+] smartphone screen. (Photo Illustration ...
Merck raises 2024 profit forecast on surging sales of cancer drug Keytruda
Merck & Co on Thursday raised its annual profit and revenue forecasts on the back of double-digit growth for its blockbuster ...
CytomX Therapeutics Announces Clinical Collaboration with Merck to Evaluate CX-801 in Combination with KEYTRUDA® (pembrolizumab)
CX-801 is a dually masked, conditionally activated IFNα2b cytokine designed using the CytomX Probody® Therapeutic Platform - - Phase 1 first-in-human study expected to start in first half of 2024 - - ...
Dow Jones Drug Giant Merck, Nvidia Eye Buy Points In Current Stock Market
Dow Jones drug giant Merck and Nvidia stock are among the best stocks to buy and watch in today's stock market action.
FDA approves Merck’s Winrevair
Winrevair is used for the treatment of adults with pulmonary arterial hypertension to increase exercise capacity, improve WHO ...
Gossamer sells rights to drug it hopes can rival a new Merck therapy
One analyst thinks the collaboration “bodes well” for Gossamer, which has had trouble convincing investors its drug seralutinib can compete on the market.
Merck’s first-quarter results beat expectations amid healthy vaccine-sales growth
Merck on Thursday reported first-quarter results that beat analysts’ expectations amid strong sales of vaccines and cancer ...
Will Higher Keytruda Sales Drive Merck's Q1
Firstly, let us look at Merck’s stock performance in recent years. MRK stock has seen strong gains of 55% from levels of $80 ...
Merck Stock Climbs After Higher-Than-Expected Sales of Cancer Drug Keytruda
Shares of U.S. drugmaker Merck are up nearly 4% in recent trading after the company said its blockbuster cancer drug Keytruda ...
Biocartis and Merck to Collaborate on Improving Patient Access to Personalized Medicine in Middle East and North Africa (MEA) Region
Biocartis (Mechelen, Belgium) announced an expansion of its collaboration with Merck Serono Middle East and Merck Saudi Ltd., both affiliates of Merck KGaA (“Merck”). The collaboration aims to improve ...
Merck raises 2024 profit forecast on strong sales of cancer drug Keytruda
Merck & Co on Thursday raised its annual profit and revenue forecasts on the back of strong sales for its blockbuster cancer ...
Loading the latest forecasts...